Next year will mark a turning point for AI in healthcare as the industry shifts from pilots and hype to accountable, integrated systems that prove to have measurable impact, according to execs.

Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic disease risk and aging.

The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring device.

The company also raised $5 million in venture debt funding.

Tampa General Hospital Cancer Institute will integrate Reimagine’s platform into its clinical pathways to reduce workforce burden and extend cancer care into the home.

Executives pointed to faster-than-expected AI adoption in healthcare, shifting regulatory signals and growing demand for AI tools that deliver measurable outcomes.

uMed’s registry platform will work alongside WellSky’s network of home-based care organizations to let patients participate in national clinical trials from home.

ADP participated as a new investor in Thatch’s $40 million Series B funding round in April, which brought the company’s total raise to $84.5 million.

The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.

Dr. Doug Fridsma, former ONC chief science officer and current CMIO at Health Universe, discusses the challenges of AI in healthcare and balancing innovation with privacy, safety and regulation.